Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Ulcerative Colitis in Non-European Ancestry Patients
NCT05119140Phase 2Active, not recruiting
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jun 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in ulcerative colitis (UC), sponsored by Icahn School of Medicine at Mount Sinai. Started Jun 2022; status: active, not recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05119140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05119140.